<?xml version='1.0' encoding='iso-8859-1'?>
<newsitem date="1997-07-29" id="root" itemid="763853" xml:lang="en">
<title>UK: P&amp;U to take 10 to 16 cents/shr charge.</title>
<headline>P&amp;U to take 10 to 16 cents/shr charge.</headline>
<dateline>LONDON 1997-07-29</dateline>
<text>
<p>Pharmacia &amp; Upjohn Inc said on Tuesday it would take a one-off charge of between $0.10 and $0.16 per share after tax against third-quarter earnings, to cover costs related to the planned merger of Pharmacia Biotech with Amersham International Plc's Life Science business.  </p>
<p>The company said it expected to incur a number of charges including the write-off of some acquired research and development costs linked to the creation of Amersham Pharmacia Biotech, in which it will have a 45 percent stake.</p>
<p>--London Newsroom +44 171 542 7717</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<dc element="dc.date.created" value="1997-07-29" />
<dc element="dc.publisher" value="Reuters Holdings Plc" />
<dc element="dc.date.published" value="1997-07-29" />
<dc element="dc.source" value="Reuters" />
<dc element="dc.creator.location" value="LONDON" />
<dc element="dc.creator.location.country.name" value="UK" />
<dc element="dc.source" value="Reuters" />
</metadata>
</newsitem>